Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...
Morning Overview on MSN
New prostate cancer cell atlas may aid earlier detection, researchers say
A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...
Single-cell sequencing is useful for a number of applications. For example, it can reveal cellular heterogeneity inside complex tissues, such as tumors. It can also provide information about how ...
A computational method called scSurv, developed by researchers at Institute of Science Tokyo, links individual cells to ...
Tumor-wide RNA splicing aberrations and their potential as therapeutic neoantigen targets. Phase 1/2, open-label, first-in-human study of the anti-GPC3 T-cell engager SAR444200 in patients with ...
Over the last two weeks, we’ve seen a flurry of biotech industry updates, from the latest precision instrument for genomic research to the first at-home RNA screening test for preventing colon cancer.
Foundation models (FMs), which are deep learning models pretrained on large-scale data and applied to diverse downstream ...
Andreas Pfenning discusses the techniques being developed and used to study neuronal heterogeneity and the therapeutic potential of his work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results